Malin Corporation

Malin Corporation Dividend

Dividend of Malin Corporation (MLC.IR) as of Oct 12, 2026.

Dividend

0.00EUR

Last updated:

How much dividend does Malin Corporation 2026 pay?

According to the latest status from October 2026, Malin Corporation paid a total of 0.00 EUR per share in dividends within the last 12 months. With the current Malin Corporation price of 7.00 EUR, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical Malin Corporation Dividends

Historical Malin Corporation Dividends
PaydateDividend

The Malin Corporation Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2019
0.00 EUR
Jan 1, 2020
0.00 EUR
Jan 1, 2021
0.00 EUR
Jan 1, 2022
0.00 EUR
Jan 1, 2023
0.00 EUR
Jan 1, 2024
0.00 EUR
Jan 1, 2025 (e)
0.00 EUR
Jan 1, 2026 (e)
0.00 EUR
The Malin Corporation Dividend history
YEARDividendYoY
est0.00EUR—
est0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—
0.00EUR—

Is the Malin Corporation Dividend Safe?

Malin Corporation has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding Malin Corporation's Dividend Distributions

Malin Corporation’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Malin Corporation's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Malin Corporation's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Malin Corporation’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Malin Corporation Stock analysis

What does Malin Corporation do? Malin Corporation PLC is an Irish company that was founded in 2014. The company is a subsidiary of Elan, a company specialized in pharmaceutical development. Malin has focused its business model on identifying, supporting, and scaling startup companies. The company supports and invests in startups in the biopharmaceutical industry that focus on new and innovative therapies. Malin offers help and advice to its portfolio companies in product development and business organization. The company has invested in various areas of the biopharmaceutical industry. For example, it has supported YumaTherapeutics, a company focused on the discovery and development of novel therapeutics for infectious diseases. Malin has also provided financial support to Seres Therapeutics, which has built a pipeline of therapeutics targeting the microbiome, the collection of microorganisms living in the gut. Malin has invested in Inivata, a company specialized in the development of cancer diagnostics. Furthermore, Malin has various other companies in its investment pipeline that deal with a variety of therapeutic possibilities. This includes therapies for genetic diseases and inherited metabolic disorders, as well as applications of gene therapy and immunotherapy. Malin Corporation PLC has also developed its own products and partnerships. One of these partnerships is with Novaerus, another Irish company specialized in the development of air purification systems. Novaerus systems use a plasma-based ion system to destroy bacteria, viruses, and fungi in the air, thus preventing infections. Malin is also involved in research collaborations. One collaboration is with University College Dublin, where Malin provides financial support for research on biopharmaceutical processes. The history of Malin Corporation PLC is characterized by a strong commitment to supporting innovative companies in the biopharmaceutical industry. The company aims to promote the growth and development of startups, offering not only financial support but also advice and expertise. Malin has diversified its investments in various areas of the biopharmaceutical industry and focuses on promoting products that improve people's health and well-being. The company has also developed its own products and partnerships to bring new technologies and therapies to the market. Overall, Malin Corporation PLC is a company specialized in supporting and promoting startups in the biopharmaceutical industry. The company is committed to developing products and therapies that have the potential to improve and prolong people's lives. Malin Corporation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Malin Corporation stock

Malin Corporation paid dividends every year for the past 0 years.

Malin Corporation is assigned to the 'Health' sector.

The dividends of Malin Corporation are distributed in EUR.

Dividend calendar 2026
Access this data via the Eulerpool API
Get Free API Key

All Key Metrics — Malin Corporation